Oncology reports

Oncol Rep · ISSN (e) 1791-2431 · 21 papers in corpus
other 2025
doi:10.3892/or.2025.8878 ·PMID:39981914

Endometrial cysts of the ovary (EMC) may develop into endometriosis (EM)‑associated ovarian cancer over time (EAOC), but the pathogenesis of this disease has not been determined. In the present study, RNA sequencing was used to identify a f…

other 2019
doi:10.3892/or.2019.7202 ·PMID:31233196

Programmed cell death 4 (PDCD4) has been identified as a tumor‑suppressor gene that inhibits neoplastic transformation, tumor progression, and protein translation. It has been reported that multiple factors participate in the regulation of …

review 2018
doi:10.3892/or.2018.6946 ·PMID:30592289

In the present study, we summarize the role of the shared and independent (epi)genetic background between endometrioid carcinoma (EC) and clear cell carcinoma (CCC), two histological subtypes of endometriosis-associated ovarian cancer (EAOC…

article 2018
doi:10.3892/or.2018.6779 ·PMID:30542723

Ovarian cancer is the one of the most lethal gynecological cancer types. MicroRNAs (miRs) are noncoding RNAs that modulate the translation of their target mRNAs via binding to a complementary sequence in the target 3' untranslated region, a…

review 2016
doi:10.3892/or.2015.4421 ·PMID:26572704

The AT-rich interacting domain‑containing protein 1A gene (ARID1A) encodes ARID1A, a member of the SWI/SNF chromatin remodeling complex. Mutation of ARID1A induces changes in expression of multiple genes (CDKN1A, SMAD3, MLH1 and PIK3IP1) vi…

article 2014
doi:10.3892/or.2014.3524 ·PMID:25333219

The aim of the present study was to investigate the role of epigenetic inactivation of the runt-related transcription factor 3 gene (RUNX3) in the malignant transformation of ovarian endometriosis. Samples obtained by microdissection and sc…

review 2012
doi:10.3892/or.2012.2184 ·PMID:23242072

The aim of our review was to identify the current information with regard to the pathogenesis and malignant transformation of adenomyosis. The current literature was reviewed by searching MEDLINE/PubMed, using the following keywords: adenom…

review 2011
doi:10.3892/or.2011.1456 ·PMID:21922146

This review summarizes data from recent molecular genetic and epidemiology studies of the generic term 'female pelvic cancer'. The English-language literature was reviewed for genetic, epigenetic, epidemiologic and environmental risk factor…

review 2010
doi:10.3892/or_00000750 ·PMID:20372830

Epithelial ovarian cancer (EOC) is the most common cause of gynecological cancer-related mortality. Clear cell EOC (cEOC) has a number of clinical features distinguishing it from other EOC because of frequent concurrence of endometriosis an…

article 2009
·PMID:19578761

Epithelial ovarian cancer (EOC) is the leading cause of death in women with gynecological malignancies. Among EOC, clear cell carcinoma (CCC) and endometrioid adenocarcinoma (EAC) differ from the other histological types with respect to the…

article 2008
doi:10.3892/or.19.4.843 ·PMID:18357365

Endometriosis is a painful reproductive and immunological disease afflicting about 7-10% of women worldwide. It is one of the most frequent benign gynaecological diseases; however, little is known about the pathogenetic processes leading to…

article 2007
doi:10.3892/or.17.6.1333 ·PMID:17487387

We previously reported that indoleamine-2,3-dioxygenase (IDO) is associated with paclitaxel resistance and that IDO serves as a marker of poor prognosis in ovarian serous adenocarcinomas (SA). In this study, to explore the role of IDO in th…

article 2005
doi:10.3892/or.13.6.1235 ·PMID:15870948

Decreased numbers of eutopic endometrial apoptotic cells have been reported in endometriotic patients, indicating the possibility of anti-apoptotic effects of their sera. Recently, we reported that the sera from endometriotic patients enhan…

other 2005
doi:10.3892/or.14.5.1385 ·PMID:16211314

Epidemiological and clinical studies have revealed that vitamin A and its derivatives (carotenoids and retinoids) can reduce the risk of ovarian tumours and may have a role in the metabolism of patients with ovarian cancer. The aim of the s…

article 2003
doi:10.3892/or.10.5.1155 ·PMID:12883673

Human endometrial tissues regenerate easily after menstruation and childbirth, suggesting the existence of endometrial stem-like cells that can survive and proliferate from a single cell over a long time. To clarify this hypothesis, limitin…

article 2001
doi:10.3892/or.8.6.1317 ·PMID:11605057

The expression of vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2) were immunohistochemically examined in both pelvic and extrapelvic endometriotic lesions. Different expressions of VEGF and COX-2 were observed in both…

article 2000
doi:10.3892/or.7.3.651 ·PMID:10767384

Twenty-five patients with ovarian clear cell carcinoma (CC-Ca) were enrolled in this study, and tumor cell expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PD-ECGF) was investigate…

other 2000
doi:10.3892/or.7.2.327 ·PMID:10671681

Although clear cell carcinoma of the ovary is considered to be a tumor with poor prognosis, the clinical characteristics has not been defined. The aim of this study was to evaluate the response of clear cell carcinoma of the ovary to first …

other 1998
doi:10.3892/or.5.4.939 ·PMID:9625851

The records of 41 patients diagnosed with adenosarcoma of the female genital tract between 1982 and 1996 were reviewed. The median age at diagnosis is 51 years (range, 14-84). The most common symptom is vaginal bleeding (71%). Clinical sign…

other 1998
doi:10.3892/or.5.1.49 ·PMID:9458291

We studied the expression of oncogenes and tumor-suppressor genes in human endometriosis in a retrospective pilot study. Sixteen patients with histologically verified pelvic endometriosis at the university-based tertiary care referral cente…

other 1995
doi:10.3892/or.2.1.37 ·PMID:21597684

Virgin female SHN and SLN mice, a high and a low spontaneous mammary tumor strains, respectively, were given a single intravenous injection of streptozotocin (2 mg/10 g body weight), resulting in a significant rise of blood glucose levels a…